Pulmonx Secures $66M in Financing to Support Commercial Acceleration of the Zephyr Valve System, a Minimally-Invasive Treatment for Severe Emphysema

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/3c9lmF8
via IFTTT